- /
- Supported exchanges
- / US
- / DYAI.NASDAQ
Dyadic International Inc (DYAI NASDAQ) stock market data APIs
Dyadic International Inc Financial Data Overview
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; and sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Dyadic International Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Dyadic International Inc data using free add-ons & libraries
Get Dyadic International Inc Fundamental Data
Dyadic International Inc Fundamental data includes:
- Net Revenue: 3 090 K
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Dyadic International Inc Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-03-31
- EPS/Forecast: -0.039
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Dyadic International Inc News
New
Dyadic outlines 2026 product revenue growth and commercialization milestones while expanding partnerships
Earnings Call Insights: Dyadic International, Inc. (DYAI) Q4 2025 MANAGEMENT VIEW * President & COO Joseph Hazelton indicated that since stepping into the President's role in June 2025, the compan...
Dyadic International, Inc. Q4 2025 Earnings Call Summary
Dyadic International, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Pivot and Operational Execution Shifted corporate strategy from a development-stage platform to a commercial, product-driven...
Dyadic (DYAI) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool. Date Wednesday, March 25, 2026 at 5 p.m. ET Call participants President and Chief Operating Officer — Joseph P. Hazelton Chief Executive Officer — Mark A. Emalfa...
Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress
Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using Dyadic’s production platform, with Dyadic eligible to receive a share of profits from product sal...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.